Sign in
CompletedNo phase

Dysvascular Amputation Self-Management of Health

Key facts

Who runs it
University of Colorado, Denver
Where
Aurora, United StatesSee the site
Trial code
Status
Completed
People taking part
35 people enrolled
Started
1 Nov 2019
Ended
31 May 2025
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Walking Biobehavioral Intervention
  • Attention Control
Record updated
13 August 2026

Who can take part

Age
50 years to 85 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 10 criteriaShow less

Who can take part

  • Within the age range of 50-85 years
  • Confirmed diagnosis of Type II Diabetes Mellitus (DM) and/or Peripheral Artery Disease (PAD)
  • Transtibial, knee disarticulation, or transfemoral lower-limb amputation (LLA) (or re-amputation) within the past 12 months
  • Participant goal of household walking or better using a prosthesis

Who cannot take part

  • Trauma or cancer-related etiology of the LLA
  • Active cancer treatment
  • Recent stroke (within 2 years)
  • Decisionally challenged individuals (MMSE score below 24)
  • Prisoners
  • Clinical discretion of principal investigator to exclude patients who are determined to be unsafe and/or inappropriate to participate in the described intervention

Where in United States

  • University of Colorado HospitalAurora, United States

About the trial

What the trial wants to find out

The purpose of this study is to determine if walking biobehavioral intervention improves physical activity after dysvascular lower limb amputation.

The 2 groups in the trial

  • Walking Biobehavioral Intervention (EXP)Treatment being tested

    The EXP group will receive biobehavioral training that is integrated into the conventional outpatient training component and is delivered over 5 months. There will be 10 biobehavioral sessions, 1 of which will be a combined biobehavioral/conventional outpatient session and the other 9 being telehealth sessions.

    Treatment: Walking Biobehavioral Intervention

  • Attention Control (CTL)Existing treatment, for comparison

    The CTL group intervention will include the same conventional outpatient training (10 sessions) as the EXP group and receive the same computer tablets with telehealth software as the EXP group (week 3 of prosthetic training).

    Treatment: Attention Control

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Improving Health Self-Management Using Walking Biobehavioral Intervention for People With Dysvascular Lower Limb Amputation
Publications
Record updated
13 August 2026